Yi Cheng

1.2k total citations · 1 hit paper
27 papers, 719 citations indexed

About

Yi Cheng is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Yi Cheng has authored 27 papers receiving a total of 719 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 6 papers in Immunology and 5 papers in Molecular Biology. Recurrent topics in Yi Cheng's work include Cancer Immunotherapy and Biomarkers (5 papers), Immunotherapy and Immune Responses (5 papers) and Visual perception and processing mechanisms (4 papers). Yi Cheng is often cited by papers focused on Cancer Immunotherapy and Biomarkers (5 papers), Immunotherapy and Immune Responses (5 papers) and Visual perception and processing mechanisms (4 papers). Yi Cheng collaborates with scholars based in China, United States and Japan. Yi Cheng's co-authors include J. Carl Barrett, Jhanelle E. Gray, Suresh S. Ramalingam, Riyaz Shah, Fumio Imamura, Yuri Rukazenkov, Byoung Chul Cho, Y. Ohe, Margarita Majem and Juliann Chmielecki and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer Research and Clinical Infectious Diseases.

In The Last Decade

Yi Cheng

26 papers receiving 711 citations

Hit Papers

Mechanisms of acquired resistance to first-line osimertin... 2018 2026 2020 2023 2018 50 100 150 200 250
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Mechanisms of acquired resistance to first-line osimertinib: Preliminary data from the phase III FLAURA study
    2018 269 citations Suresh S. Ramalingam, Yi Cheng et al. Annals of Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yi Cheng China 12 400 318 165 126 125 27 719
Zhengwei Dong China 17 341 0.9× 405 1.3× 213 1.3× 278 2.2× 78 0.6× 39 785
Miiru Izumi Japan 12 232 0.6× 246 0.8× 222 1.3× 74 0.6× 115 0.9× 31 660
Katherine Hastings United States 5 367 0.9× 233 0.7× 181 1.1× 117 0.9× 158 1.3× 11 604
Hester van Cruijsen Netherlands 16 389 1.0× 227 0.7× 351 2.1× 137 1.1× 224 1.8× 23 962
Thomas Boulet France 17 352 0.9× 127 0.4× 206 1.2× 220 1.7× 50 0.4× 36 686
Kailun Fei China 14 481 1.2× 265 0.8× 184 1.1× 101 0.8× 187 1.5× 23 706
Heng Lin China 11 566 1.4× 189 0.6× 250 1.5× 170 1.3× 374 3.0× 26 944
Linda K. Han United States 14 117 0.3× 396 1.2× 94 0.6× 174 1.4× 82 0.7× 26 926
María T. Vlachaki United States 18 197 0.5× 452 1.4× 196 1.2× 42 0.3× 87 0.7× 51 958
Hong Bu China 11 157 0.4× 142 0.4× 253 1.5× 105 0.8× 92 0.7× 39 729

Countries citing papers authored by Yi Cheng

Since Specialization
Citations

This map shows the geographic impact of Yi Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Cheng more than expected).

Fields of papers citing papers by Yi Cheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Cheng. The network helps show where Yi Cheng may publish in the future.

Co-authorship network of co-authors of Yi Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Yi Cheng. A scholar is included among the top collaborators of Yi Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yi Cheng. Yi Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Wen, et al.. (2025). Impact of glycolysis enzymes and metabolites in regulating DNA damage repair in tumorigenesis and therapy. Cell Communication and Signaling. 23(1). 44–44. 5 indexed citations
2.
Qiu, Miao‐Zhen, Yuxian Bai, Jufeng Wang, et al.. (2024). Addition of SHR-1701 to first-line capecitabine and oxaliplatin (XELOX) plus bevacizumab for unresectable metastatic colorectal cancer. Signal Transduction and Targeted Therapy. 9(1). 349–349. 5 indexed citations
3.
Yang, Biao, et al.. (2024). Advances in understanding the role of immune checkpoint LAG-3 in tumor immunity: a comprehensive review. Frontiers in Oncology. 14. 1402837–1402837. 5 indexed citations
4.
Jin, Zhichao, et al.. (2022). Use of proton pump inhibitors are associated with higher mortality in hospitalized patients with COVID-19. Journal of Global Health. 12. 5005–5005. 5 indexed citations
5.
6.
Xu, Xiaojing, Minfeng Gan, Yi Cheng, et al.. (2021). Multifaceted glycoadjuvant@AuNPs inhibits tumor metastasis through promoting T cell activation and remodeling tumor microenvironment. Journal of Nanobiotechnology. 19(1). 376–376. 10 indexed citations
7.
Cheng, Yi, Yan Li, Jie Rao, et al.. (2020). Research progress on inflammatory factors of thyroid-associated ophthalmopathy. SHILAP Revista de lepidopterología.
8.
Li, Dan, Shanshan Weng, Chenhan Zhong, et al.. (2020). Risk of Second Primary Cancers Among Long-Term Survivors of Breast Cancer. Frontiers in Oncology. 9. 1426–1426. 27 indexed citations
9.
10.
Wu, Na, Erdem Tüzün, Yi Cheng, et al.. (2020). Central Role of T Follicular Helper Cells in Myasthenia Gravis. Nöro Psikiyatri Arşivi. 58(1). 68–72. 3 indexed citations
11.
Hu, Yuxiang, Jun Wang, Jie Rao, et al.. (2020). Comparison of peripheral blood B cell subset ratios and B cell-related cytokine levels between ocular and generalized myasthenia gravis. International Immunopharmacology. 80. 106130–106130. 25 indexed citations
12.
Xu, Xiaojing, Yi Cheng, Xiaoqin Yang, et al.. (2019). Tumor Cells Modified with Newcastle Disease Virus Expressing IL-24 as a Cancer Vaccine. Molecular Therapy — Oncolytics. 14. 213–221. 13 indexed citations
13.
Hu, Yuxiang, Yi Cheng, Xiaoxuan Xu, et al.. (2019). Pretreatment neutrophil-to-lymphocyte ratio predicts prognosis in patients with diabetic macular edema treated with ranibizumab. BMC Ophthalmology. 19(1). 194–194. 22 indexed citations
14.
Ge, Xiaoxu, Jiawei He, Yi Cheng, et al.. (2019). The prognostic value of tumor-infiltrating lymphocytes in colorectal cancer differs by anatomical subsite: a systematic review and meta-analysis. World Journal of Surgical Oncology. 17(1). 85–85. 75 indexed citations
15.
Li, Dan, Chenhan Zhong, Yi Cheng, et al.. (2019). A Competing Nomogram to Predict Survival Outcomes in Invasive Micropapillary Breast Cancer. Journal of Cancer. 10(27). 6801–6812. 15 indexed citations
16.
Guo, Yi, Yanfeng Wang, Xiaohui Peng, et al.. (2018). Tumour endothelial marker 1/endosialin-mediated targeting of human sarcoma. European Journal of Cancer. 90. 111–121. 26 indexed citations
17.
Ramalingam, Suresh S., Yi Cheng, C. Zhou, et al.. (2018). Mechanisms of acquired resistance to first-line osimertinib: Preliminary data from the phase III FLAURA study. Annals of Oncology. 29. viii740–viii740. 269 indexed citations breakdown →
18.
Huang, Xin, Yuxiang Hu, Fuqing Zhou, et al.. (2018). Altered whole-brain gray matter volume in high myopia patients. Neuroreport. 29(9). 760–767. 19 indexed citations
19.
Hu, Yuxiang, et al.. (2017). The prognostic value of lymphocyte-to-monocyte ratio in retinopathy of prematurity. International Journal of Ophthalmology. 10(11). 1716–1721. 26 indexed citations
20.
Laniti, Denarda Dangaj, Evripidis Lanitis, Aizhi Zhao, et al.. (2013). Novel Recombinant Human B7-H4 Antibodies Overcome Tumoral Immune Escape to Potentiate T-Cell Antitumor Responses. Cancer Research. 73(15). 4820–4829. 98 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhengwei Dong Breakdown of academic impact, for papers by Miiru Izumi Breakdown of academic impact, for papers by Katherine Hastings Breakdown of academic impact, for papers by Hester van Cruijsen Breakdown of academic impact, for papers by Thomas Boulet Breakdown of academic impact, for papers by Kailun Fei Breakdown of academic impact, for papers by Heng Lin Breakdown of academic impact, for papers by Linda K. Han Breakdown of academic impact, for papers by María T. Vlachaki Breakdown of academic impact, for papers by Hong Bu
Rankless by CCL
2026